Advertisement

Pancreatic Ductal Adenocarcinoma and Its Variants

  • David C. Chhieng
  • Edward B. Stelow
Part of the Essentials in Cytopathology book series (EICP, volume 3)

Abstract

Pancreatic ductal adenocarcinoma (PDA) and its variants comprise, 85% to 90% of all pancreatic cancers. It is usually a disease of older individuals and affected patients are often in their seventh to eighth decades of life. The disease is uncommon in patients 40 years or younger and men are affected slightly more frequently than women. The classic clinical symptomatic triad includes epigastric pain with radiation to the back, jaundice, and weight loss. Unfortunately, these findings are nonspecific and can occur in patients with other malignancies or benign diseases, such as gallstones. In addition, many patients only have minimal or vague symptoms when the disease is still curable and in the early stage, especially when it arises in the body or tail of the pancreas.

Keywords

Chronic Pancreatitis Small Cell Carcinoma Pancreatic Ductal Adenocarcinoma Signet Ring Cell Multinucleated Giant Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Centeno BA. Fine needle aspiration biopsy of the pancreas. Clin Lab Med 1998;18:401–427.PubMedGoogle Scholar
  2. Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997;45:387–393.PubMedCrossRefGoogle Scholar
  3. Cohen MB, Egerter DP, Holly EA, Ahn DK, Miller TR. Pancreatic adenocarcinoma: regression analysis to identify improved cytologic criteria. Diagn Cytopathol 1991;7:341–345.PubMedCrossRefGoogle Scholar
  4. Eloubeidi MA, Chen VK, Eltoum IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003;98:2663–2668.PubMedGoogle Scholar
  5. Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285–292.PubMedCrossRefGoogle Scholar
  6. Erickson RA, Garza AA. Impact of endoscopic ultrasound on the management and outcome of pancreatic carcinoma. Am J Gastroenterol 2000;95:2248–2254.PubMedCrossRefGoogle Scholar
  7. Goldstein D, Carroll S, Apte M, Keogh G. Modern management of pancreatic carcinoma. Intern Med J 2004;34:475–481.PubMedCrossRefGoogle Scholar
  8. Gupta RK, Wakefield SJ. Needle aspiration cytology, immunocytochemistry, and electron microscopic study of unusual pancreatic carcinoma with pleomorphic giant cells. Diagn Cytopathol 1992;8:522–527.PubMedCrossRefGoogle Scholar
  9. Hughes JH, Cohen MB. Fine-needle aspiration of the pancreas. Pathology 1996;4:389–407.PubMedGoogle Scholar
  10. Lin F, Staerkel G. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer 2003;99:44–50.PubMedCrossRefGoogle Scholar
  11. Mitchell ML, Carney CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol 1985;83:171–176.PubMedGoogle Scholar
  12. Rahemtullah A, Misdraji J, Pitman MB. Adenosquamous carcinoma of the pancreas: cytologic features in 14 cases. Cancer 2003;99: 372–378.PubMedCrossRefGoogle Scholar
  13. Robins DB, Katz RL, Evans DB, Atkinson EN, Green L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytol 1995;39:1–10.PubMedGoogle Scholar
  14. Silverman JF, Dabbs DJ, Finley JL, Geisinger KR. Fine-needle aspiration biopsy of pleomorphic (giant cell) carcinoma of the pancreas. Cytologic, immunocytochemical, and ultrastructural findings. Am J Clin Pathol 1988;89:714–720.PubMedGoogle Scholar
  15. Stelow EB, Pambuccian SE, Bardales RH, et al. The cytology of pancreatic foamy gland adenocarcinoma. Am J Clin Pathol 2004;121:893–897.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • David C. Chhieng
    • 1
  • Edward B. Stelow
    • 2
  1. 1.Department of PathologyUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of PathologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations